A shock toxin that produces disseminated intravascular coagulation and multiple organ failure

American Journal of the Medical Sciences

Volumn 322, Issue 4, 2001, Pages 222-228

  Hardaway, Robert M ^a,b   Vasquez, Yvonne ^a  

^a Paul L Foster School of Medicine   (United States)

^b Texas Tech Health Sciences Center   (United States)

Author keywords

Acute respiratory distress syndrome; Disseminated intravascular coagulation; Multiple organ failure; Septic shock; Shock; Traumatic shock

Indexed keywords

AMINOPHOSPHOLIPID; PLASMINOGEN ACTIVATOR; TOXIN;

ADULT RESPIRATORY DISTRESS SYNDROME; CAUSE OF DEATH; DISSEMINATED INTRAVASCULAR CLOTTING; ESCHERICHIA COLI; HUMAN; HYPOVOLEMIA; HYPOVOLEMIC SHOCK; INJURY; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; REVIEW; SEPSIS; SEPTIC SHOCK; SWINE; THROMBOGENESIS; TRAUMATIC SHOCK;

EID: 0034768627     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200110000-00013     Document Type: Review

References (46)

1. Experimental shock-cause of the low blood pressure produced by muscle injury
2. Prevention of ARDS with plasminogen activator
3. The influence of extracorporeal handling of blood on hemorrhagic shock in dogs
4. Care of the wounded in the United States army from 1775-1991
5. Hypovolemic and traumatic shock
6. Classification of shock
7. Shock lung
8. The role of corticosteroids in the treatment of shock
9. Vasoactive drugs in the treatment of shock
10. Antibody therapy in shock
11. Interleukin-1 receptor antagonist significantly reduces death from sepsis
12. Editor's note
13. A controlled trial of HA-IA in a canine model of Gram-negative septic shock
14. Safety and potential efficiency of an aerosolized surfactant in human sepsis induced acute respiratory distress syndrome
15. Reflecting and regrouping after failed trials, sepsis researchers forge on
16. Why sepsis trials fail
17. Strategies for the treatment of sepsis
18. Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome. Why no magic bullets?
19. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis
20. Anti-inflamatory therapies to treat sepsis and septic shock: A reassessment
21. The fluid model of the structure of cell membranes
22. Studies on the organization of plasma membrane phospholipids in human erythrocytes
23. Erythrocyte membrane lipid organization during the sickling process
24. Toxicity of polymerized hemoglobin solution
25. Breaching the blood-brain barrier
26. Disseminated intravascular coagulation: A cause of shock
27. Clotting mechanism in endotoxin shock-a manifestation of DIC
28. Fibrin embolism with defibrination as one of the end results during placenta abruptio
29. Lower nephron nephrosis
30. Production of lower nephron nephrosis in dogs by means of an episode of intravascular clotting
31. Intravascular thrombi and the intestinal factor of irreversible shock
32. Pathologic study of intravascular coagulation following incompatible blood transfusion in dogs
33. Production of acute hemorrhagic pancreatitis in dogs by means of an episode of DIC
34. Pulmonary microthrombi
35. Disseminated intravascular coagulation syndromes
36. Intensive study and treatment of shock in man
37. Mechanism of action of fibrinolysin in the prevention of "irreversible" hemorrhagic shock
38. Prevention of adult respiratory distress syndrome with plasminogen activator in pigs
39. Prevention of multiple organ failure with plasminogen activator
40. Traumatic and septic shock alias post-trauma critical illness
41. DIC in sepsis
42. Treatment of severe acute respiratory distress syndrome: A final report on a phase I study
43. A new theory of traumatic and septic shock